In examining recent analyst actions, we gain insights into how financial experts perceive Humana. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings ...

Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Humana (HUM – Research Report) and Acumen Pharmaceuticals ...

In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Humana (HUM – Research Report), with a price target of ...

UnitedHealth Group is seen as the pacesetter for Medicare Advantage, but some analysts view its poor first quarter as an ...

Baxter covers the Healthcare sector, focusing on stocks such as UnitedHealth, CVS Health, and Humana. Currently, the analyst consensus on Humana is a Moderate Buy with an average price target of ...

The firm has an Outperform rating on Humana. The Fly notes that back in October, Humana sued U.S. health agencies seeking to reverse a cut to crucial Medicare quality ratings, which translates to ...

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance ...

The rise of Medicare Advantage plans offers seniors new choices within the complex framework of Medicare options. From personalized care preferences to expanded benefits, more than half of ...

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.